This time next year, the inaugural class of medical students at the new 91С»Æ³µ-Bowling Green Campus will be attending their very first course, kicking off an exciting new opportunity for future Kentucky clinicians.
News
![Dr._Karpf_2015[1].jpg](/sites/default/files/article/images/Dr._Karpf_2015%5B1%5D.jpg)

Epidemiologist Dr. Camara Phyllis Jones will present the next installment of the 91С»Æ³µ Dean's Distinguished Lecture Series, "Achieving Health Equity: Tools for a National Campaign Against Racism."
Jones is research director on social determinants of health and equity for the U.S. Centers for Disease Control and Prevention. She is a family physician and epidemiologist whose work focuses on the impact of racism on the health and well-being of the nation.
Last month, the UK HealthCare ALS Clinic earned a coveted recognition from the ALS Association: ALS Association Certified Treatment Center of Excellence. The certification honors UK's commitment to ALS research and patient care, which centers around a multidisciplinary approach where ALS patients see a variety of specialists in a single visit.
(Read more about our ALSA Certification here.)


The NIH Center of Biomedical Research Excellence (COBRE) on Obesity and Cardiovascular Diseases, in collaboration with the Center for Clinical and Translational Sciences (CCTS) announce the availability of limited funds to support pilot projects focused on research examining obesity-associated diseases (cardiovascular, diabetes, others). These pilot grants are intended to assist investigators new to this area of research to generate sufficient data to be competitive for extramural funding.
Funding Amount:
Everyday, approximately 15 people learn they have Amyotrophic Lateral Sclerosis. ALS is a progressive neurological disease that affects the nerve cells in the brain and the spinal cord, eventually stealing from its victims the ability to walk, dress, write, speak, swallow and breathe. Most ALS patients die within five years of diagnosis, and currently, there is no cure.

UK HealthCare’s University of Kentucky Albert B. Chandler Hospital remains the No. 1 hospital in Kentucky and the Bluegrass Region, according to the U.S. News & World Report's Best Hospitals Rankings released today.
In addition, four major health care areas have achieved top 50 national rankings, three of them for the first time. UK HealthCare rankings included: #50 in Cancer, #44 in Neurology and Neurosurgery, #43 in Geriatrics, and #37 in Diabetes and Endocrinology.

A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.
Tumor relapse is a common problem following cancer treatment, because primary tumor cells often contain therapy-resistance cancer cells that continue to proliferate after the therapy-sensitive cells have been eliminated.


By Vice President for Research Lisa Cassis Thursday
In May, it was my distinct pleasure to present Matthew Gentry with a University Research Professorship award. He was one of 16 faculty, selected by their own colleges, who have demonstrated excellence in scholarship and creative work that addresses scientific, social, cultural and economic challenges in our region and around the world.


Owensboro Health has joined the University of Kentucky Markey Cancer Center Research Network (MCCRN).
With this new relationship, patients in Western Kentucky and Southern Indiana will have easier access to innovative clinical research studies. Areas of research will include epidemiology, prevention and early detection of cancer. Markey Cancer Center is a National Cancer Institute-designated cancer center, which will open up NCI-led trials in addition to MCCRN trials.

New findings from University of Kentucky faculty published in Alzheimer’s Research and Therapy demonstrate the value of physician-pharmacist teams in providing elderly care.

A peek at Matthew Gentry's professional profile reveals a long list of honors and awards.
A National Science Foundation Faculty Career Development Award.A National Institutes of Health Pathway to Independence Award.A University of Kentucky Research Professorship Award.Three U.S. Patents.A five-year, $8.5 million National Institutes of Health grant to pursue a cure for Lafora disease.Wait. Lafora disease? From a lab that also studies biofuels?


With a $4.5 million award from the Centers for Medicare and Medicaid Services, researchers in the University of Kentucky Center for Health Services Research (CHSR) have established the Kentucky Consortium for Accountable Health Communities (KC-AHC) to address the health-related social needs of vulnerable patients across the Commonwealth.



